SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-015319
Filing Date
2019-01-24
Accepted
2019-01-24 07:30:34
Documents
4
Period of Report
2019-01-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d686991d8k.htm 8-K 18753
2 EX-99.1 d686991dex991.htm EX-99.1 14978
3 GRAPHIC g686991g19e34.jpg GRAPHIC 1927
4 GRAPHIC g686991g92e51.jpg GRAPHIC 13335
  Complete submission text file 0001193125-19-015319.txt   56235
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Filer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37766 | Film No.: 19538615
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences